Log in

NYSE:ALBAlbemarle Stock Price, Forecast & News

$78.89
+3.14 (+4.15 %)
(As of 07/10/2020 04:00 PM ET)
Add
Compare
Today's Range
$75.34
Now: $78.89
$79.04
50-Day Range
$67.97
MA: $76.91
$86.74
52-Week Range
$48.89
Now: $78.89
$99.40
Volume1.07 million shs
Average Volume994,221 shs
Market Capitalization$8.39 billion
P/E Ratio16.54
Dividend Yield1.95%
Beta1.46
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. Its Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and value-added lithium specialties, as well as reagents, such as butyllithium and lithium aluminum hydride for applications in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes, life science, pharmaceutical, and other markets. It also offers cesium products for the chemical and pharmaceutical industries; zirconium, barium, and titanium products for various pyrotechnical applications; technical services, such as the handling and use of reactive lithium products; and recycling services for lithium-containing by-products. The company's Bromine Specialties segment offers bromine and bromine-based solutions for fire safety, chemical synthesis, mercury control, water purification, beef and poultry processing, and other industrial applications, as well as oil and gas well drilling, and completion fluids applications; and tertiary amines, biocides, disinfectants, and sanitizers. Its Catalysts segment offers performance catalyst solutions comprising hydroprocessing catalysts together with isomerization and akylation catalysts; fluidized catalytic cracking catalysts and additives; and performance catalyst solutions comprising organometallics and curatives. It serves energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, crop protection, and custom chemistry services markets. The company was founded in 1994 and is headquartered in Charlotte, North Carolina.
Read More
Albemarle logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.1Community Rank: 2.7Dividend Strength: 4.2Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.36 out of 5 stars


Industry, Sector and Symbol

Industry Plastics materials & resins
Sub-IndustrySpecialty Chemicals
CUSIP01265310
Phone980-299-5700

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$3.59 billion
Cash Flow$8.07 per share
Book Value$38.61 per share

Profitability

Net Income$533.23 million

Miscellaneous

Employees6,000
Market Cap$8.39 billion
Next Earnings Date8/5/2020 (Confirmed)
OptionableOptionable

Receive ALB News and Ratings via Email

Sign-up to receive the latest news and ratings for ALB and its competitors with MarketBeat's FREE daily newsletter.

Albemarle (NYSE:ALB) Frequently Asked Questions

How has Albemarle's stock been impacted by COVID-19 (Coronavirus)?

Albemarle's stock was trading at $70.07 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, ALB shares have increased by 12.6% and is now trading at $78.89. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Albemarle?

25 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Albemarle in the last year. There are currently 4 sell ratings, 14 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Albemarle.

When is Albemarle's next earnings date?

Albemarle is scheduled to release its next quarterly earnings announcement on Wednesday, August 5th 2020. View our earnings forecast for Albemarle.

How can I listen to Albemarle's earnings call?

Albemarle will be holding an earnings conference call on Wednesday, August 5th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Albemarle's earnings last quarter?

Albemarle Co. (NYSE:ALB) issued its quarterly earnings data on Wednesday, May, 6th. The specialty chemicals company reported $1.00 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.85 by $0.15. The specialty chemicals company had revenue of $738.85 million for the quarter, compared to analyst estimates of $769.26 million. Albemarle had a return on equity of 15.34% and a net margin of 14.50%. Albemarle's revenue for the quarter was down 11.2% compared to the same quarter last year. During the same period last year, the company earned $1.23 earnings per share. View Albemarle's earnings history.

How often does Albemarle pay dividends? What is the dividend yield for Albemarle?

Albemarle declared a quarterly dividend on Tuesday, May 5th. Stockholders of record on Friday, June 12th will be paid a dividend of $0.385 per share on Wednesday, July 1st. This represents a $1.54 dividend on an annualized basis and a dividend yield of 1.95%. The ex-dividend date of this dividend is Thursday, June 11th. View Albemarle's dividend history.

What guidance has Albemarle issued on next quarter's earnings?

Albemarle updated its second quarter 2020 After-Hours earnings guidance on Wednesday, May, 6th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $700-775 million, compared to the consensus revenue estimate of $775.7 million.

What price target have analysts set for ALB?

25 Wall Street analysts have issued twelve-month price targets for Albemarle's stock. Their forecasts range from $39.50 to $116.00. On average, they expect Albemarle's share price to reach $74.54 in the next twelve months. This suggests that the stock has a possible downside of 5.5%. View analysts' price targets for Albemarle.

Has Albemarle been receiving favorable news coverage?

News headlines about ALB stock have been trending very negative on Sunday, according to InfoTrie Sentiment. InfoTrie identifies positive and negative news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Albemarle earned a coverage optimism score of -3.8 on InfoTrie's scale. They also assigned media coverage about the specialty chemicals company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near term. View the latest news about Albemarle.

Are investors shorting Albemarle?

Albemarle saw a drop in short interest in June. As of June 15th, there was short interest totaling 13,970,000 shares, a drop of 9.0% from the May 31st total of 15,360,000 shares. Based on an average trading volume of 1,730,000 shares, the short-interest ratio is presently 8.1 days. Currently, 13.2% of the shares of the stock are short sold. View Albemarle's Current Options Chain.

Who are some of Albemarle's key competitors?

What other stocks do shareholders of Albemarle own?

Who are Albemarle's key executives?

Albemarle's management team includes the following people:
  • Mr. Luther C. Kissam IV, Chairman, Pres & CEO (Age 54)
  • Mr. Scott A. Tozier, Exec. VP & CFO (Age 53)
  • Mr. Donald J. LaBauve Jr., VP, Corp. Controller & Chief Accounting Officer (Age 52)
  • Ms. Karen G. Narwold, Exec. VP, Chief Admin. Officer, Gen. Counsel & Corp. Sec. (Age 59)
  • Mr. David Ryan, VP of Corp. Strategy & Investor Relations

What is Albemarle's stock symbol?

Albemarle trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALB."

Who are Albemarle's major shareholders?

Albemarle's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Robecosam AG (0.14%), Envestnet Asset Management Inc. (0.10%), Moody National Bank Trust Division (0.04%), State of Alaska Department of Revenue (0.04%), Legacy Capital Partners Inc. (0.02%) and HNP Capital LLC (0.01%). Company insiders that own Albemarle stock include Deeanne J Marlow, Eric Norris, Karen G Narwold, Luther C Iv Kissam and Scott Tozier. View institutional ownership trends for Albemarle.

Which major investors are selling Albemarle stock?

ALB stock was sold by a variety of institutional investors in the last quarter, including Robecosam AG, State of Alaska Department of Revenue, Municipal Employees Retirement System of Michigan, Moody National Bank Trust Division, and Legacy Capital Partners Inc.. Company insiders that have sold Albemarle company stock in the last year include Karen G Narwold, Luther C Iv Kissam, and Scott Tozier. View insider buying and selling activity for Albemarle.

Which major investors are buying Albemarle stock?

ALB stock was bought by a variety of institutional investors in the last quarter, including Envestnet Asset Management Inc., HNP Capital LLC, Fulton Breakefield Broenniman LLC, Exane Derivatives, Bangor Savings Bank, Contravisory Investment Management Inc., and Ellevest Inc.. Company insiders that have bought Albemarle stock in the last two years include Deeanne J Marlow, and Eric Norris. View insider buying and selling activity for Albemarle.

How do I buy shares of Albemarle?

Shares of ALB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Albemarle's stock price today?

One share of ALB stock can currently be purchased for approximately $78.89.

How big of a company is Albemarle?

Albemarle has a market capitalization of $8.39 billion and generates $3.59 billion in revenue each year. The specialty chemicals company earns $533.23 million in net income (profit) each year or $6.04 on an earnings per share basis. Albemarle employs 6,000 workers across the globe.

What is Albemarle's official website?

The official website for Albemarle is www.albemarle.com.

How can I contact Albemarle?

Albemarle's mailing address is 4250 CONGRESS STREET SUITE 900, CHARLOTTE NC, 28209. The specialty chemicals company can be reached via phone at 980-299-5700 or via email at [email protected]

This page was last updated on 7/12/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.